Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Caillou

Showing results (141-150 of 152) with videos related to

Pageof 16
Sort By:
Cancer|September 15, 1989
Prognostic factors in primary gastrointestinal non-Hodgkin's lymphoma. A multivariate analysis, report of 106 cases, and review of the literatureM B Azab, M Henry-Amar, P Rougier, et al.
Endocrine-Related Cancer|December 2, 2010
Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome?D Deandreis, A Al Ghuzlan, S Leboulleux, et al.
The Journal of Clinical Endocrinology and Metabolism|May 11, 2006
Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapyC Durante, N Haddy, E Baudin, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1985
Reproducibility and prognostic value of different non-Hodgkin's lymphoma classifications: study based on the clinicopathologic relations found in the EORTC trial (20751)C De Wolf-Peeters, B Caillou, J Diebold, et al.
Henry Ford Hospital Medical Journal|January 1, 1992
Statistical analysis of histomorphological findings in medullary thyroid carcinoma: distinction between the different familial forms of the disease. G.E.T.C. Groupe d'Etude des Tumeurs a CalcitonineB Franc, M Rosenberg-Bourgin, B Auvert, et al.
Human Pathology|August 19, 1999
Medullary thyroid microcarcinoma: a clinicopathologic retrospective study of 38 patients with no prior familial diseaseS Guyétant, F Dupre, J C Bigorgne, et al.
Oncogene|August 16, 2011
ROS-generating NADPH oxidase NOX4 is a critical mediator in oncogenic H-Ras-induced DNA damage and subsequent senescenceU Weyemi, O Lagente-Chevallier, M Boufraqech, et al.
European Journal of Endocrinology|March 30, 2010
Adrenocortical carcinoma: is the surgical approach a risk factor of peritoneal carcinomatosis?S Leboulleux, D Deandreis, A Al Ghuzlan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1978
Preliminary results of chemo-radiotherapy followed or not by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma. Correlation of the results with WHO categorisationJ L Misset, G Mathé, M Tubiana, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1978
Preliminary results of chemoradiotherapy followed (or not ) by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma: correlation of the results with WHO categorizationJ L Misset, G Mathé, M Tubiana, et al.
Pageof 16

Showing results (141-150 of 152) with videos related to

Sort By:
Pageof 16
Cancer|September 15, 1989
Prognostic factors in primary gastrointestinal non-Hodgkin's lymphoma. A multivariate analysis, report of 106 cases, and review of the literatureM B Azab, M Henry-Amar, P Rougier, et al.
Endocrine-Related Cancer|December 2, 2010
Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome?D Deandreis, A Al Ghuzlan, S Leboulleux, et al.
The Journal of Clinical Endocrinology and Metabolism|May 11, 2006
Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapyC Durante, N Haddy, E Baudin, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1985
Reproducibility and prognostic value of different non-Hodgkin's lymphoma classifications: study based on the clinicopathologic relations found in the EORTC trial (20751)C De Wolf-Peeters, B Caillou, J Diebold, et al.
Henry Ford Hospital Medical Journal|January 1, 1992
Statistical analysis of histomorphological findings in medullary thyroid carcinoma: distinction between the different familial forms of the disease. G.E.T.C. Groupe d'Etude des Tumeurs a CalcitonineB Franc, M Rosenberg-Bourgin, B Auvert, et al.
Human Pathology|August 19, 1999
Medullary thyroid microcarcinoma: a clinicopathologic retrospective study of 38 patients with no prior familial diseaseS Guyétant, F Dupre, J C Bigorgne, et al.
Oncogene|August 16, 2011
ROS-generating NADPH oxidase NOX4 is a critical mediator in oncogenic H-Ras-induced DNA damage and subsequent senescenceU Weyemi, O Lagente-Chevallier, M Boufraqech, et al.
European Journal of Endocrinology|March 30, 2010
Adrenocortical carcinoma: is the surgical approach a risk factor of peritoneal carcinomatosis?S Leboulleux, D Deandreis, A Al Ghuzlan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1978
Preliminary results of chemo-radiotherapy followed or not by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma. Correlation of the results with WHO categorisationJ L Misset, G Mathé, M Tubiana, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1978
Preliminary results of chemoradiotherapy followed (or not ) by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma: correlation of the results with WHO categorizationJ L Misset, G Mathé, M Tubiana, et al.
Pageof 16